FDA information regarding Biosimilars

Posted in Latest News on August 26, 2013.

The FDA has created a pathway for the approval of biosimilar products, but has not yet approved a biological product as biosimilar or interchangeable. There is no date-certain for when these products will be approved—some estimates are three to five years.
The Board of Pharmacy has established a link on its website to the FDA pathway for approval of biosimilar biological products.



More Latest News

New Legislation Impacting Your Profession
April 17, 2018

Click here to view a full list of bill summaries from the 2018 Florida Legislative Session that may impact your profession. Continue reading


First Quarterly Performance Report Released for the 2017-2018 Fiscal Year
April 15, 2018

The Quarterly Performance Report for the first quarter of the 2017-2018 fiscal year is now available online. Continue reading